Loading provider…
Loading provider…
Ophthalmology Physician in Nashville, TN
NPI: 1124387709Primary Practice Location
VANDERBILT UNIVERSITY MEDICAL CENTER
2200 Childrens Way, Nashville, TN
Primary Employer
Vanderbilt Medical Group
vanderbilthealth.com
HQ Phone
Get MD, MPH, CPH Sapna's Phone NumberMobile
Get MD, MPH, CPH Sapna's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTN State Medical License

American Board of Ophthalmology
Ophthalmology
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 310 | 471 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 183 | 263 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 162 | 194 |
| 4 | 67028Injection of drug into eye | 153 | 337 |
| 5 | J9035Injection, bevacizumab, 10 mg | 67 | 127 |
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Incidence of and Risk Factors for Cataract in Anterior Uveitis.
Authors: James Rosenbaum, Nirali Bhatt, Grace Levy-Clarke, Jennifer Thorne, Eric Suhler
Journal: Am J Ophthalmol
Publication Date: 2023-07-05
Lead Sponsor: JHSPH Center for Clinical Trials
Intervention / Treatment: BIOLOGICAL: Adalimumab (ADA), DRUG: Conventional immunosuppression (CON)
Lead Sponsor: JHSPH Center for Clinical Trials
Collaborators: National Eye Institute (NEI)
Intervention / Treatment: DRUG: Dexamethasone intravitreal implant 0.7 mg, DRUG: Intravitreal Methotrexate 400 µg, DRUG: Intravitreal Ranibizumab 0.5 mg
Lead Sponsor: Vanderbilt University Medical Center
Intervention / Treatment: OTHER: Non invasive visual acuity testing